MAPT and depressive symptom measurement: Despite the fact that depression is a risk factor for AD, our previous study showed no evidence of increased Aβ/tau in the brain tissue from patients with depression in either early (18–50 years old) and late (51–90 years old) stage of life [11], suggesting that depression may increase risk of AD through other factors.